1. I. P. Ashmarin, N. Yu. Sarycheva, G. I. Vlasova, V. N. Kalikhevich, and A. A. Kamenskii, “Use of tuftsin to correct pharmacological impairments of behavior in white rats,” Byull. Éksperim. Biol. Med., 13, No. 2, 178 (1987).
2. A. V. Val’dman, M. M. Kozlovskaya, I. P. Ashmarin, M. F. Mineeva, and K. V. Anokhin, “Central effects of the tetrapeptide tuftsin,” Byull. Éksperim. Biol. Med., 92, No. 7, 31 (1981).
3. A. L. Zabludovskii, M. Ya. Maizelis, and R. I. Kruglikov, “Characteristics of the function of higher parts of the central nervous system in rats subjected to acute hypoxia during the antenatal period,” Byull. Éksperim. Biol. Med., 8, 928–930 (1976).
4. B. M. Kogan and M. V. Nechaeva, “A sensitive and rapid method for the simultaneous estimation of dopamine, noradrenaline, serotonin, and 5-hydroxyindoleacetic acid in a single specimen,” Lab. Delo, 5, 301 (1979).
5. M. M. Kozlovskaya, I. I. Kozlovskii, E. A. Val’dman, and S. B. Seredenin, “Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress,” Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 4, 264–268 (2002).